Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
Jun Ho YiSeok Jin KimDok Hyun YoonCheolwon SuhMyung Hee ChangDeok Hwan YangJae-Cheol JoShin Young HyunHyeon-Seok EomJeong-Ok LeeJi Hyun KwonSang Hoon HanSeung Shin LeeJae-Yong KwakSe Hyung KimDae Sik KimJi Hyun LeeSung Yong OhHun Mo RyooHyo Jung KimWon Seog KimPublished in: Cancer communications (London, England) (2021)